Market News

Medtronic Plc (MDT) Position Boosted by Bank Of The Ozarks; Medifast (MED) Shareholder Engaged Capital Has Lowered Position

Medtronic plc (NYSE:MDT) Logo

Bank Of The Ozarks increased its stake in Medtronic Plc (MDT) by 41.08% based on its latest 2017Q4 regulatory filing with the SEC. Bank Of The Ozarks bought 8,514 shares as the company’s stock declined 4.15% with the market. The institutional investor held 29,240 shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q4, valued at $2.36 million, up from 20,726 at the end of the previous reported quarter. Bank Of The Ozarks who had been investing in Medtronic Plc for a number of months, seems to be bullish on the $115.97B market cap company. The stock increased 1.42% or $1.19 during the last trading session, reaching $85.57. About 1.69 million shares traded. Medtronic plc (NYSE:MDT) has declined 3.54% since May 16, 2017 and is downtrending. It has underperformed by 15.09% the S&P500.

Glenn W. Welling decreased its stake in Medifast Inc (MED) by 66.49% based on its latest 2017Q4 regulatory filing with the SEC. Engaged Capital Llc sold 525,000 shares as the company’s stock rose 23.31% while stock markets declined. The hedge fund run by Glenn W. Welling held 264,549 shares of the packaged foods company at the end of 2017Q4, valued at $18.47 million, down from 789,549 at the end of the previous reported quarter. Engaged Capital Llc who had been investing in Medifast Inc for a number of months, seems to be less bullish one the $1.56 billion market cap company. The stock increased 0.29% or $0.37 during the last trading session, reaching $129.12. About 62,699 shares traded. Medifast, Inc. (NYSE:MED) has risen 107.05% since May 16, 2017 and is uptrending. It has outperformed by 95.50% the S&P500.

Bank Of The Ozarks, which manages about $263.80 million US Long portfolio, decreased its stake in Bank Of The Ozarks (NASDAQ:OZRK) by 51,340 shares to 1.88 million shares, valued at $90.89M in 2017Q4, according to the filing.

Among 29 analysts covering Medtronic (NYSE:MDT), 19 have Buy rating, 0 Sell and 10 Hold. Therefore 66% are positive. Medtronic had 83 analyst reports since August 10, 2015 according to SRatingsIntel. The rating was maintained by Wedbush with “Neutral” on Wednesday, June 1. The firm has “Equal-Weight” rating given on Thursday, March 29 by Morgan Stanley. Goldman Sachs upgraded Medtronic plc (NYSE:MDT) on Friday, November 13 to “Conviction Buy List” rating. The stock of Medtronic plc (NYSE:MDT) has “Buy” rating given on Wednesday, February 21 by Needham. As per Tuesday, August 22, the company rating was maintained by BTIG Research. The stock of Medtronic plc (NYSE:MDT) has “Buy” rating given on Monday, June 13 by SunTrust. The stock has “Buy” rating by BMO Capital Markets on Tuesday, December 12. The stock of Medtronic plc (NYSE:MDT) earned “Outperform” rating by William Blair on Thursday, July 6. As per Wednesday, August 23, the company rating was maintained by Northland Capital. On Tuesday, September 29 the stock rating was maintained by RBC Capital Markets with “Outperform”.

More notable recent Medtronic plc (NYSE:MDT) news were published by: Nasdaq.com which released: “Detailed Research: Economic Perspectives on Medtronic, NVIDIA, NutriSystem, AmTrust Financial Services, Kratos …” on May 16, 2018, also Seekingalpha.com with their article: “Medtronic Should Focus On Aggressive Deleveraging” published on May 15, 2018, Globenewswire.com published: “Medtronic Announces New Paid Family Care Leave Benefits” on May 01, 2018. More interesting news about Medtronic plc (NYSE:MDT) were released by: Streetinsider.com and their article: “Medtronic (MDT) Launches US Study of Drug-Eluting Stents to Evaluate Treatment of Bifurcation Lesions in Patients …” published on May 16, 2018 as well as Investingnews.com‘s news article titled: “Medtronic Begins US Study of Drug-Eluting Stents to Evaluate Treatment of Bifurcation Lesions in Patients with …” with publication date: May 16, 2018.

Investors sentiment decreased to 1.02 in Q4 2017. Its down 0.10, from 1.12 in 2017Q3. It dropped, as 65 investors sold MDT shares while 427 reduced holdings. 111 funds opened positions while 393 raised stakes. 1.04 billion shares or 2.98% less from 1.07 billion shares in 2017Q3 were reported. Boston Family Office holds 9,259 shares or 0.08% of its portfolio. Copeland Capital Mgmt Ltd Liability Corp stated it has 76,077 shares. Edgemoor invested in 0.08% or 7,841 shares. Shelter Insurance Retirement Plan accumulated 2.92% or 82,022 shares. Capital Ltd Ca has 28,148 shares. Arrowgrass Capital (Us) Lp reported 0.04% stake. Moreover, Private Ocean Limited Co has 0% invested in Medtronic plc (NYSE:MDT). Piper Jaffray Company holds 0.01% or 77 shares. Factory Mutual holds 1.13M shares or 0.95% of its portfolio. Zeke Limited Liability reported 0.56% of its portfolio in Medtronic plc (NYSE:MDT). Marco Inv Mgmt Ltd Liability reported 190,656 shares. Signaturefd Ltd Liability Corporation, Georgia-based fund reported 5,662 shares. California State Teachers Retirement Sys holds 2.52M shares or 0.42% of its portfolio. Personal Capital Advisors Corporation has invested 0% in Medtronic plc (NYSE:MDT). Robeco Institutional Asset Management Bv reported 161,571 shares or 0.07% of all its holdings.

Investors sentiment increased to 1.33 in Q4 2017. Its up 0.33, from 1 in 2017Q3. It improved, as 14 investors sold MED shares while 56 reduced holdings. 36 funds opened positions while 57 raised stakes. 10.23 million shares or 0.32% more from 10.20 million shares in 2017Q3 were reported. 69,755 are held by Kennedy Cap Mgmt. Leucadia accumulated 0.03% or 4,975 shares. Schroder Inv Mngmt Gp holds 12,800 shares. Guggenheim Cap Llc owns 30,821 shares. Hightower Advsr Ltd Com, Illinois-based fund reported 7,096 shares. Rice Hall James Limited Liability holds 0.11% of its portfolio in Medifast, Inc. (NYSE:MED) for 38,770 shares. Credit Suisse Ag holds 11,047 shares or 0% of its portfolio. Ny State Teachers Retirement System holds 11,475 shares or 0% of its portfolio. Teacher Retirement Of Texas has 3,266 shares for 0% of their portfolio. Northwestern Mutual Wealth holds 0% or 18 shares. Moreover, Eqis Management has 0.07% invested in Medifast, Inc. (NYSE:MED) for 20,336 shares. 3,013 were accumulated by Citigroup Inc. Driehaus Cap Ltd Liability Company, Illinois-based fund reported 47,200 shares. Alps Advsr has 0% invested in Medifast, Inc. (NYSE:MED). C M Bidwell Associate Ltd holds 1,445 shares or 0.09% of its portfolio.

Since March 8, 2018, it had 0 buys, and 3 sales for $4.87 million activity. MACDONALD MICHAEL C also sold $3.47M worth of Medifast, Inc. (NYSE:MED) on Thursday, March 8.

Engaged Capital Llc, which manages about $194.47 million and $770.72M US Long portfolio, upped its stake in Benchmark Electrs Inc (NYSE:BHE) by 181,680 shares to 951,462 shares, valued at $27.69M in 2017Q4, according to the filing.

Analysts await Medifast, Inc. (NYSE:MED) to report earnings on August, 14. They expect $1.00 EPS, up 58.73% or $0.37 from last year’s $0.63 per share. MED’s profit will be $12.07 million for 32.28 P/E if the $1.00 EPS becomes a reality. After $1.01 actual EPS reported by Medifast, Inc. for the previous quarter, Wall Street now forecasts -0.99% negative EPS growth.

Among 3 analysts covering Medifast (NYSE:MED), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Medifast had 8 analyst reports since August 10, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, August 16 by DA Davidson. The firm has “Buy” rating given on Friday, September 15 by DA Davidson. Sidoti upgraded Medifast, Inc. (NYSE:MED) on Monday, January 11 to “Buy” rating. On Friday, January 29 the stock rating was initiated by Wunderlich with “Hold”. The firm has “Hold” rating by Zacks given on Monday, August 10. The rating was downgraded by Sidoti on Monday, November 30 to “Neutral”. The stock of Medifast, Inc. (NYSE:MED) earned “Neutral” rating by Sidoti on Thursday, April 19. The stock has “Buy” rating by Sidoti on Monday, October 5.

Another recent and important Medifast, Inc. (NYSE:MED) news was published by Seekingalpha.com which published an article titled: “Medifast’s (MED) CEO Dan Chard on Q1 2018 Results – Earnings Call Transcript” on May 04, 2018.

Medifast, Inc. (NYSE:MED) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *